Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
US12201612B2 · kind B2 · utility
1Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2018 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | May 12, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of alcohol use by an alcohol use disorder patient; in preventing relapse into alcohol use by an alcohol use disorder patient; in the promotion of alcohol abstinence by an alcohol use disorder patient; in the treatment of the symptoms of depression or anxiety associated with alcohol use disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.